Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int Endod J ; 54(1): 38-45, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-32876967

RESUMEN

AIM: To evaluate the association between the promoter region of defensin beta 1 (DEFB1) genetic polymorphisms and persistent apical periodontitis (PAP) in Brazilian patients. METHODOLOGY: Seventy-three patients with post-treatment PAP (PAP group) and 89 patients with root filled teeth with healed and healthy periradicular tissues (healed group) were included (all teeth had apical periodontitis lesions at the beginning of the treatment). Patients who had undergone at least 1 year of follow-up after root canal treatment were recalled, and their genomic DNA was extracted from saliva. Two single nucleotide polymorphisms (SNPs) in DEFB1 at the g. -52G>A (rs1799946) and g. -20G>A (rs11362) positions were analysed using real-time polymerase chain reaction. The chi-squared test was performed, and the odds ratios were calculated using Epi Info 3.5.2. Logistic regression analysis in the codominant model, using the time of follow-up as a variable, was used to evaluate the SNP-SNP interaction. All tests were performed with an established alpha of 0.05 (P = 0.05). RESULTS: For the rs11362 polymorphism in the codominant and recessive models, patients who carried two copies of the T allele had a significantly lower risk of developing PAP (P = 0.040 and P = 0.031, respectively). For the rs1799946 polymorphism in DEFB1 in the codominant and recessive models, carrying one copy of the T allele significantly increased the risk of developing PAP (P = 0.007 and P = 0.031, respectively). In the logistic regression, both polymorphisms were associated with PAP as well as the SNP-SNP interaction (P < 0.0001). CONCLUSIONS: Polymorphisms in DEFB1 genes were associated with the development of post-treatment persistent apical periodontitis.


Asunto(s)
Periodontitis Periapical , beta-Defensinas , Brasil , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Periodontitis Periapical/genética , Polimorfismo de Nucleótido Simple , Regiones Promotoras Genéticas/genética , beta-Defensinas/genética
2.
Int J Pharm ; 484(1-2): 131-7, 2015 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-25724133

RESUMEN

Cutaneous permeation is a critical parameter when topical application of sunscreens containing antioxidants is considered. The aim of this study was to evaluate the cutaneous penetration of most marketed UV-filters combined with trans-resveratrol (RES) and beta-carotene (BTC) since few studies report skin penetration when such compounds are applied. Formulations containing octocrylene, octyl methoxycinnamate, avobenzone and bemotrizinole were prepared and supplemented or not with BTC, or with RES, or with both compounds in combination. Penetration studies were performed using Franz vertical diffusion cells and porcine ear skin as the biological membrane. The quantification of UV-filters and antioxidants in the stratum corneum (SC), viable epidermis plus dermis and receptor fluid was performed by HPLC. Results suggested that UV-filters and antioxidants did not permeate the skin but were retained for 12h post application. About 90% and 80%, respectively, of the total penetrated amount of UV-filters and antioxidants was found in the SC. Interestingly, it was observed that BTC, alone or combined with RES, reduced the skin retention of UV-filters on average by 63%. In conclusion, this study demonstrated that the combination of antioxidants and UV-filters in sunscreens is advantageous for cutaneous penetration, since BTC and BTC+RES improved sunscreen safety by reducing delivery of the four UV-filters in the study into SC and viable epidermis.


Asunto(s)
Absorción Cutánea/efectos de los fármacos , Absorción Cutánea/efectos de la radiación , Estilbenos/farmacocinética , Protectores Solares/farmacocinética , Rayos Ultravioleta , Administración Cutánea , Animales , Técnicas de Cultivo de Órganos , Resveratrol , Absorción Cutánea/fisiología , Estilbenos/administración & dosificación , Protectores Solares/administración & dosificación , Porcinos , Rayos Ultravioleta/efectos adversos
4.
Rev Bras Med ; 24(12): 1001-3, 1967 Dec.
Artículo en Portugués | MEDLINE | ID: mdl-5620765
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA